Abstract
The globalization of stem cell science is increasingly being shaped by the emerging economies of the Asia/Pacific region. Undaunted and unhampered by the more established views of the commercialization of science, countries such as India are constructing models of innovation, policies and patterns of investment that challenge such orthodoxies. This report examines the position of India within the globalization of stem cell science, its adjustments to the developing knowledge market in this field and its particular contribution to the likely future of this promising bioeconomy.
| Original language | English |
|---|---|
| Pages (from-to) | 75-89 |
| Number of pages | 15 |
| Journal | Regenerative Medicine |
| Volume | 2 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2007 |